the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

DNB’s 5G network first in Southeast Asia to use Ericsson RedCap

PETALING JAYA: Ericsson has carried out tests on Malaysia’s 5G network deployed by Digital Nasional Bhd (DNB) for the first implementation and validation in Southeast Asia of Ericsson’s pre-commercial Reduced Capability (RedCap) software.

The tests were carried out in collaboration with MediaTek, using its 5G RedCap test platform in Malaysia.

Ericsson RedCap is a new radio access network (RAN) software solution that enhances existing 5G use cases and enables new ones for devices such as smartwatches, other wearables, and industrial sensors by lowering complexity and extending battery life.

RedCap is the next evolution of 5G technology that complements the industry progress of cellular IoT technologies with benefits that include reduced device chipset cost, lower complexity and less power consumption while delivering higher data rates comparable to LTE Cat-1 to LTE Cat-4. It can also support advanced Standalone 5G NR functionalities such as enhanced positioning and network slicing.

Ericsson Malaysia, Sri Lanka and Bangladesh head David Hägerbro said: “RedCap will broaden connectivity options for diverse use cases and enhance usage across consumer, industrial and enterprise devices that don’t require the full range of 5G’s capabilities. It will enhance 5G connectivity for everything from consumer wearables to industrial sensors in a way that is both cost- and energy-efficient, unlocking a whole range of new use cases.”

With service providers continuously enhancing network capabilities to seize the opportunities offered by 5G, the next wave will help them grow their consumer business and enable new industry applications, all while improving system performance and energy efficiency, he added

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings